NCT06170190 2025-11-17
A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Completed
Clinical Trials
4 trialsNCT05458219 2025-11-10
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Recruiting
NCT05857332 2025-06-25
CSG-1906-101
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1 Recruiting
NCT05636215 2025-03-20
A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Recruiting